Trial intelligence / Profile preview

Remimazolam tosylate plus esketamine for anesthesia during endoscopic variceal ligation

ChiCTR2100052235Phase 4Recruiting

Sponsor
Liaocheng City People's Hospital
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of remimazolam and esketamine in Gastroesophageal varices (GEV) (3 arms), sponsored by Liaocheng City People's Hospital. Primary endpoint: Number of rescue cases and total rescue drug amount. Started Nov 2021; status: recruiting.

02

Drugs

remimazolamesketamine
03

Conditions

Gastroesophageal varices (GEV)

Beyond the preview

Go deeper on ChiCTR2100052235.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100052235.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call